Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The Proteomics Challenge

This article was originally published in Start Up

Executive Summary

The fact that proteomic diversity is most likely several logs greater than genomic diversity is only one reason why moving from gene expression-based analyses to proteomics-based drug development presents a daunting challenge. The large issues go well beyond protein isolation and characterization: Genomics simply doesn't tell you how proteins function in vivo, and companies are just now beginning to amass and integrate the tools to correlate protein structure and function. In many ways, proteomics heralds the second coming of rational drug design, enabled now by high-throughput tools and the algorithms of computational biology. But whether structure-guided drug development will prove to be efficient or cost-effective remains to be seen.
Advertisement

Related Content

Downward Trends in Proteomics Deal Making
Downward Trends in Proteomics Deal Making
MelTec GMBH
Protein Arrays: When Genes Are Not Enough
Integrative Proteomics Inc.
Syrrx Inc.

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC090367

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel